Evidence map›Paper›PMID 35224340›Full record

ArticleACS omega2022

Paper-Based Progesterone Sensor Using an Allosteric Transcription Factor.

Marjon Zamani, Josh Dupaty, R C Baer, Uros Kuzmanovic, Andy Fan, Mark W Grinstaff, James E Galagan, Catherine M Klapperich

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marjon ZamaniDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.ORCID https://orcid.org/0000-0002-8553-5340
Josh DupatyDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
R C BaerDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
Uros KuzmanovicDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
Andy FanDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
Mark W GrinstaffDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.ORCID https://orcid.org/0000-0002-5453-3668
James E GalaganDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.
Catherine M KlapperichDepartment of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, United States.ORCID https://orcid.org/0000-0001-6103-849X
Boston University · US

Funding

TRAINING GRANTS IN ENVIROMENTAL TOXICOLOGYT32ES007020 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1985 to 2024
$13.1M
Novel Biosensors based on Mining Bacterial Transcription FactorsR01EB029795 · NIBIB · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI GALAGAN, JAMES E, KLAPPERICH, CATHERINE M. · 2020 to 2024
$2.6M
NIBIB NIH HHS R01 EB029795NIEHS NIH HHS T32 ES007020
6 · The paper itself

Abstract

Progesterone monitoring is an essential component of in vitro fertilization treatments and reproductive management of dairy cows. Gold-standard biosensors for progesterone monitoring rely on antibodies, which are expensive and difficult to procure. We have developed an alternative transcription factor-based sensor that is superior to conventional progesterone biosensors. Here, we incorporate this transcription factor-based progesterone sensor into an affordable, portable paperfluidic format to facilitate widespread implementation of progesterone monitoring at the point of care. Oligonucleotides labeled with a fluorescent dye are immobilized onto nitrocellulose via a biotin-streptavidin interaction. In the absence of progesterone, these oligonucleotides form a complex with a transcription factor that is fluorescently labeled with tdTomato. In the presence of progesterone, the fluorescent transcription factor unbinds from the immobilized DNA, resulting in a decrease in tdTomato fluorescence. The limit of detection of our system is 27 nm, which is a clinically relevant level of progesterone. We demonstrate that transcription factor-based sensors can be incorporated into paperfluidic devices, thereby making them accessible to a broader population due to the portability and affordability of paper-based devices.

Identifiers

PMID35224340
PMCPMC8867790
OpenAlexW4210574400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.